Receiving a non-compliance letter from the NYSE is a significant negative event for any listed company. It indicates that the company's stock is not meeting the exchange's minimum requirements, in this case, the trading price of its ADS. This situation puts Concord Medical at risk of being delisted if it cannot regain compliance. Such news typically has a negative impact on investor confidence and can lead to a decrease in stock price in the short term.